Autoimmune hepatitis
MONDO:0016264Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.
Also known as: autoimmune liver disease, autoimmune hepatitis, autoimmune chronic active hepatitis, autoimmune hepatitis with centrilobular necrosis, chronic autoimmune hepatitis, AIH, autoimmune chronic hepatitis
66 clinical trials for this condition and its sub-types, 30 tagged with Autoimmune hepatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Autoimmune hepatitis
-
Autoimmune cholangitis 1 trial
-
Autoimmune hepatitis type 1 0 trials
-
Autoimmune hepatitis type 2 0 trials
-
Autoimmune hepatitis type 3 0 trials
-
Seronegative autoimmune hepatitis 0 trials
-
AI could help doctors personalize treatment for autoimmune hepatitis
Knowledge-focused OngoingThis study uses artificial intelligence to analyze data from 5,000 people with autoimmune hepatitis. The goal is to create a computer model that can predict which patients will respond well to standard therapy within 6 to 12 months. By identifying these patterns early, doctors ma…
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
1,200-Patient study aims to predict liver failure risks
Knowledge-focused OngoingThis observational study follows 1,222 adults with liver cirrhosis to understand why some develop serious complications like fluid buildup or bleeding. Participants have check-ups every six months, including questionnaires, physical exams, and imaging. The goal is to build better…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC